Evidence map›Paper›PMID 24982150›Full record

Trial reportProceedings of the National Academy of Sciences of the United States of America2014

Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery.

Sandro Santagata, Livia S Eberlin, Isaiah Norton, David Calligaris, Daniel R Feldman, Jennifer L Ide, Xiaohui Liu, Joshua S Wiley, Matthew L Vestal, Shakti H Ramkissoon and 9 more

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 1 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 1 synthesis or guideline pooled it, 257 citations in OpenAlex.

  1. Pooled it
  2. Intraoperative assessment of tumor margins during glioma resection by desorption electrospray ionization-mass spectrometry.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Ambient ionization mass spectrometry in brain cancer diagnosis.Journal of mass spectrometry and advances in the clinical lab · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Rapid detection of IDH mutations in gliomas by intraoperative mass spectrometry.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Article
  18. Review
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Sandro SantagataDepartments of Pathology,Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115;Department of Cancer Biology, Harvard Medical School and Dana-Farber Cancer Institute, Boston, MA 02115;
Livia S EberlinDepartment of Chemistry andCenter for Analytical Instrumentation Development, Purdue University, West Lafayette, IN 47907;
Isaiah NortonNeurosurgery, and.
David CalligarisNeurosurgery, and.
Daniel R FeldmanDepartments of Pathology,Neurosurgery, and.
Jennifer L IdeNeurosurgery, and.
Xiaohui LiuNeurosurgery, and.
Joshua S WileyDepartment of Chemistry andCenter for Analytical Instrumentation Development, Purdue University, West Lafayette, IN 47907;
Matthew L VestalNeurosurgery, and.
Shakti H RamkissoonDepartments of Pathology,Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115;
Daniel A OrringerNeurosurgery, and.
Kristen K GillDepartments of Pathology.
Ian F DunnNeurosurgery, and.
Dora Dias-SantagataDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02115; and.
Keith L LigonDepartments of Pathology,Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115;Department of Medical Oncology, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA 02215.
Ferenc A JoleszRadiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115;
Alexandra J GolbyNeurosurgery, and.
R Graham CooksDepartment of Chemistry andCenter for Analytical Instrumentation Development, Purdue University, West Lafayette, IN 47907; cooks@purdue.edu Nathalie_Agar@dfci.harvard.edu.
Nathalie Y R AgarDepartment of Cancer Biology, Harvard Medical School and Dana-Farber Cancer Institute, Boston, MA 02115;Neurosurgery, andRadiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115; cooks@purdue.edu Nathalie_Agar@dfci.harvard.edu.
Apath (United States) · USPurdue University West Lafayette · USBrigham and Women's Hospital · USHarvard University · USCenter for Cancer Research · US

Funding

IMAGE GUIDED THERAPY CENTERP41RR019703 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · PI JOLESZ, FERENC A · 2010 to 2011
$8.6M
Real-Time Stereotactic Mass Spectrometry Tissue Analysis for Intraoperative NeuroDP2OD007383 · OD · BRIGHAM AND WOMEN'S HOSPITAL · PI AGAR, NATHALIE YR · 2010 to 2010
$2.7M
Assaying GBM growth and therapy response in single cells and tumorspheres (PQ17)R01CA170592 · NCI · DANA-FARBER CANCER INST · PI LIGON, KEITH LLOYD, MANALIS, SCOTT R · 2012 to 2015
$2.0M
Heat Shock Directed Drug Discovery For The Treatment Of GliomasK08NS064168 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI SANTAGATA, SANDRO · 2008 to 2012
$900k
Tissue Imaging Using Desorption Electrospray Ionization Mass SpectrometryR21EB009459 · NIBIB · PURDUE UNIVERSITY · PI COOKS, ROBERT GRAHAM · 2009 to 2010
$384k
NCI NIH HHS R01 CA170592NCI NIH HHS R01 RO1CA170592NCRR NIH HHS P41 RR019703NCRR NIH HHS P41RR019703NIBIB NIH HHS 1R21EB009459]01NIBIB NIH HHS R21 EB009459NIH HHS 1DP2OD00738301NIH HHS DP2 OD007383NINDS NIH HHS K08 NS064168NINDS NIH HHS K08NS064168
6 · The paper itself

Abstract

For many intraoperative decisions surgeons depend on frozen section pathology, a technique developed over 150 y ago. Technical innovations that permit rapid molecular characterization of tissue samples at the time of surgery are needed. Here, using desorption electrospray ionization (DESI) MS, we rapidly detect the tumor metabolite 2-hydroxyglutarate (2-HG) from tissue sections of surgically resected gliomas, under ambient conditions and without complex or time-consuming preparation. With DESI MS, we identify isocitrate dehydrogenase 1-mutant tumors with both high sensitivity and specificity within minutes, immediately providing critical diagnostic, prognostic, and predictive information. Imaging tissue sections with DESI MS shows that the 2-HG signal overlaps with areas of tumor and that 2-HG levels correlate with tumor content, thereby indicating tumor margins. Mapping the 2-HG signal onto 3D MRI reconstructions of tumors allows the integration of molecular and radiologic information for enhanced clinical decision making. We also validate the methodology and its deployment in the operating room: We have installed a mass spectrometer in our Advanced Multimodality Image Guided Operating (AMIGO) suite and demonstrate the molecular analysis of surgical tissue during brain surgery. This work indicates that metabolite-imaging MS could transform many aspects of surgical care.

Indexed as

Brain NeoplasmsGliomaMagnetic Resonance ImagingFemaleGlutaratesHumansIntraoperative CareMaleMass SpectrometryRadiographyalpha-hydroxyglutarateGlutaratesbrain cancerIDH1intrasurgical diagnosismass spectrometry imagingoncometabolite

Identifiers

PMID24982150
PMCPMC4121790
OpenAlexW2121668219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.